• "Spreading the ideas of freedom loving people on matters regarding high finance, politics, constructionist Constitution, and mental masturbation of all types"

Chiron and GSK- GlaxoSmithKline Corona Virus Patents? | patent US2006257852 | European patent EP3172319B1 for Vaccine ?

MIavatar

Silver Miner
Joined
Nov 15, 2016
Messages
526
Likes
299
#1
Not sure if you guys have seen this. What do you think? Then there was a vaccine patent in the EU?

In 2006, USA company “Chiron” Corp applied for & was granted the Corona virus patent?


patent US2006257852
https://pubchem.ncbi.nlm.nih.gov/patent/US2006257852#section=Patent-Abstract
patent View

Severe acute respiratory syndrome coronavirus


Patent:


US2006257852
This web page summarizes information in PubChem about patent US2006257852. This includes chemicals mentioned, as reported by PubChem contributors, as well as other content, such as title, abstract, and International Patent Classification (IPC) codes. To read more about how this page was constructed, please visit the PubChem patents help page.
1Primary Patent Identifier

New Window


US2006257852

2Patent Submission Date

New Window


2006/11/16

3Patent Title

New Window


Severe acute respiratory syndrome coronavirus

4Patent Abstract

New Window


An outbreak of a virulent respiratory virus, now known as Severe Acute Respiratory Syndrome (SARS), was identified in Hong Kong, China and a growing number of countries around the world in 2003. The invention relates to nucleic acids and proteins from the SARS coronavirus. These nucleic acids and proteins can be used in the preparation and manufacture of vaccine formulations, diagnostic reagents, kits, etc. The invention also provides methods for treating SARS by administering small molecule antiviral compounds, as well as methods of identifying potent small molecules for the treatment of SARS.

5Patent URL

New Window
http://appft.uspto.gov/netacgi/nph-Parser?p=1&u=/netahtml/PTO/search-adv.html&r=1&f=G&l=50&d=PG01&s1=20060257852.PN.&OS=PN/20060257852&RS=PN/20060257852

6Patent Identifier Synonyms

New Window


US20060257852


US20060257852.A1.20061116


US20060257852A1


US2006257852.A1.20061116


US2006257852A1

7Patent Applicant

New Window


CHIRON CORP [US]

8Patent Inventor

New Window


CHIEN DAVID [US]


DONNELLY JOHN [US]


GREGERSEN JENS P [DE]


HAN JANG [US]


HOUGHTON MICHAEL [US]


KLENK HANS D [DE]


MASIGNANI VEGA [IT]


POLO JOHN M [US]


RAPPUOLI RINO [IT]


SEO MI-YOUNG [KR]


SONG HYUN C [US]


STADLER KONRAD [AU]


VALIANTE NICHOLAS [US]


WEINER AMY [US]

9Patent Chemicals

New Window

9.1PubChem Compounds
New Window
1,804 items
View More Rows & Details
That was sold to pharmaceutical & vaccine making giant “GSK- GlaxoSmithKline..
Now we have talks about no vaccine and how we are at least a year out from this. that’s a lie
In 2014 a Vaccine was patented. European patent EP3172319B1 .

DETAILED DESCRIPTION


55
[0038] The present invention provides a coronavirus comprising a variant replicase gene which, when expressed in
the coronavirus, causes the virus to have reduced pathogenicity compared to a corresponding coronavirus which com-
prises the wild-type replicase gene.

EP 3 172 319 B1


CORONAVIRUS

[0039] Gammacoronavirus is a genus of animal virus belonging to the family Coronaviridae. Coronaviruses are en-
veloped viruses with a positive-sense single-stranded RNA genome and a helical symmetry.
[0040] The genomic size of coronaviruses ranges from approximately 27 to 32 kilobases, which is the longest size for
any known RNA virus.

[0041] Coronaviruses primarily infect the upper respiratory or gastrointestinal tract of mammals and birds. Five to six
different currently known strains of coronaviruses infect humans. The most publicized human coronavirus, SARS-CoV
which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper
and lower respiratory tract infections and can also cause gastroenteritis. Middle East respiratory syndrome coronavirus
(MERS-CoV) also causes a lower respiratory tract infection in humans. Coronaviruses are believed to cause a significant
percentage of all common colds in human adults.

[0042] Coronaviruses also cause a range of diseases in livestock animals and domesticated pets, some of which can
be serious and are a threat to the farming industry. Economically significant coronaviruses of livestock animals include
infectious bronchitis virus (IBV) which mainly causes respiratory disease in chickens and seriously affects the poultry
industry worldwide; porcine coronavirus (transmissible gastroenteritis, TGE) and bovine coronavirus, which both result
in diarrhoea in young animals. Feline coronavirus has two forms, feline enteric coronavirus is a pathogen of minor clinical
significance, but spontaneous mutation of this virus can result in feline infectious peritonitis (FIP), a disease associated
with high mortality.
https://randythym.com/2020/01/25/th...rus-has-an-english-patent-number-ep3172319b1/

The corona virus that suddenly appeared in China in the Wuhan region and that is said to have started on an animal market is covered by an English patent. This is a patent number EP3172319B1 developed by Erica Bickerton on it Pirbright Institute in Surrey, England. The Pirbright Institute (Bill & Melinda Gates) specializes in the study of infectious diseases in farm animals.
It was granted approval in 2019.
 

the_shootist

Trump 2020
Midas Member
Midas Supporter ++
Joined
May 31, 2015
Messages
42,397
Likes
67,862
#2
Big pharma always has their hands in there somewhere
 

Buck

Village Idiot
Midas Member
Site Supporter ++
Joined
Apr 13, 2011
Messages
10,152
Likes
10,121
#3
so, they patent the virus on one side of the planet, then, patent the cure on the other side

how in the hell is the average citizen, of any country on the planet, supposed to keep up with that charade?



oh, wait, we're not supposed to have to do that
 

MIavatar

Silver Miner
Joined
Nov 15, 2016
Messages
526
Likes
299
#4
thought Id put some info about Chiron corp here.


https://en.wikipedia.org/wiki/Chiron_Corporation
Chiron Corporation (/ˈkaɪrɒn/ KY-ron)[1] was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.[2]


Early history
Chiron was founded in 1981 by chairman, William J. Rutter, president and chief executive, Professor Edward Penhoet, and vice president for research, Pablo DT Valenzuela. All were academics from the University of California; Penhoet at Berkeley, where he continued to lecture, and the others from San Francisco.[1] Chiron formed a partnership with the Swiss pharmaceutical giant, Ciba-Geigy Ltd.,[1] through the Biocine Company,[3][4] to use genetic engineering to develop vaccines and to treat, prevent and diagnose diseases such as AIDS, herpes and malaria.[1][5] Other partnerships included Thicon Inc. to develop a growth factor hormone for the treatment of wounds and Merck & Co to develop an improvement to their existing hepatitis B vaccine.[1] In 1986, Professor Penhoet said: "Our business strategy is to dominate small markets rather than take a small presence in a broad market." The niche that Chiron was focusing on was ophthalmology, which Mr. Penhoet said was "big enough to be interesting, but small enough to service with 40 salespeople."[1] Professor Penhoet also stated that Chiron was set up to provide the enabling technology for others to use under license,[1] and later saying that Chiron was "as close to a virtual corporation as you can be", with few fixed assets but more relationships.[6]
 

TAEZZAR

LADY JUSTICE ISNT BLIND, SHES JUST AFRAID TO WATCH
Midas Member
Midas Supporter ++
GIM Hall Of Fame
Joined
Apr 2, 2010
Messages
18,213
Likes
34,541
Location
ORYGUN
#5
My understanding is that each year the virus is a bit different & they have to wait for the "strain" to develop before they can come up with a vaccine for that strain.
NOW this does not, in any way, discount ANY backhanded, dirty tricks, that big pharma is capable of ! :angry then happy::make happy:
 
Joined
Nov 15, 2016
Messages
526
Likes
299
#7
I've been researching the patent and was wondering if this is when they first aerosoled it?

http://appft.uspto.gov/netacgi/nph-Parser?p=1&u=/netahtml/PTO/search-adv.html&r=1&f=G&l=50&d=PG01&s1=20060257852.PN.&OS=PN/20060257852&RS=PN/20060257852
77. A method for treating a patient suffering from SARS, comprising: administering to the patient a therapeutically effective dose of a molecule of less than 1000 g/mol.

78. The method of claim 77, wherein the molecule has an aromatic region and greater than one heteroatom selected from O, S, or N.

79. A method for treating a patient suffering from SARS, comprising: administering to the patient a therapeutically effective dose of a compound selected from: a nucleoside analog, a peptoid, an oligopeptide, a polypeptide a protease inhibitor, a 3C-like protease inhibitor, a papain-like protease inhibitor, or an inhibitor of an RNA dependent RNA polymerase.

80. A method for treating a patient suffering from SARS, comprising: administering to the patient a steroidal anti-inflammatory drug in combination with at least one antiviral compound.

81. A method for treating a patient suffering from SARS, comprising: administering to the patient a therapeutically effective dose of a compound selected from: acyclovir, gancyclovir, vidarabidine, foscamet, cidofovir, amantidine, ribavirin, trifluorothymidine, zidovudine, didanosine, zalcitabine, an antiviral compound listed in Table 1; an antiviral compound listed in Table 2; or an interferon.

82. The method of claim 81, wherein the interferon is an interferon-.alpha. or an interferon-.beta..

83. The method of any one of claims 77 to 82, wherein the molecule or compound is delivered by inhalation.

EDIT:

Some more on Bill Gates connection to Chiron Corp

https://www.gatesfoundation.org/Med...es/2000/10/Margaret-Lui-MD-New-Senior-Advisor
Most recently, Dr. Liu was a consultant to various projects in the areas of vaccine research and gene therapy. Previously, she was Vice President of Vaccine Research and Gene Therapy at the Chiron Corporation, a biotech firm in California, and a Senior Director at Merck & Co., Inc., Kenilworth NJ USA. Dr. Liu also has served on the faculty of the Harvard Medical School.

"The Bill & Melinda Gates Foundation is having a tremendous impact on efforts to improve people's lives. I am very pleased and excited to be part of their team of global health professionals and scientists dedicated to vaccines, and look forward to participating in the successful prevention and containment of a number of infectious diseases," said Dr. Liu.

https://www.keionline.org/book/timelines/microsoft-gates-foundation-timeline
The Bill and Melinda Gates Foundation has enormous assets and is growing in size, in part due to a generous 2006 pledge stock from Warren Buffett, the investor. In 2009, the BMGF reported more than $3 billion in grants, and $409 million in operating expenses, mostly directed at projects to improve the lives of poor persons living in developing countries. In the area of public health, there is no donor as influential as the Gates Foundation except the U.S. government.
 
Last edited:

arminius

Platinum Bling
Platinum Bling
Midas Supporter ++
Joined
Jun 6, 2011
Messages
5,267
Likes
7,507
#8
How is it, that the greatest amount of money, within this paradigm we live in, is created through destruction. War, hatred politics, divisiveness and division by racial or sexual characteristic, and now the ultimate division, pestilence.
 

Buck

Village Idiot
Midas Member
Site Supporter ++
Joined
Apr 13, 2011
Messages
10,152
Likes
10,121
#9
because Peace is Free???
 

Usury

Site Supporter
Site Supporter
Platinum Bling
Joined
Apr 1, 2010
Messages
4,649
Likes
4,139
#10
My understanding is that each year the virus is a bit different & they have to wait for the "strain" to develop before they can come up with a vaccine for that strain.
NOW this does not, in any way, discount ANY backhanded, dirty tricks, that big pharma is capable of ! :angry then happy::make happy:
Exactly. This was for the SARS/MERS version of coronavirus not the current COVID19. This is meaningless for the same reason that annual flu vaccines are a hoax—they won’t work after the virus mutates.
 
Joined
Nov 15, 2016
Messages
526
Likes
299
#11
Exactly. This was for the SARS/MERS version of coronavirus not the current COVID19. This is meaningless for the same reason that annual flu vaccines are a hoax—they won’t work after the virus mutates.

Well, I guess my question is then. Why do these virus out breaks get consistently worse right after a new vaccine trial? Mr Gates is an avowed pop reductionist and he has access to all the funds in the world. Maybe it's just a coincidence?